期刊文献+

兰尼碱受体2与心脏疾病 被引量:2

原文传递
导出
摘要 兰尼碱受体(ryanodine receptor,RyR)2为心脏Ca2+释放通道之一,因它和一种植物碱——兰尼碱具有很高的亲和力与特异性,故而得名.它为同源四聚体细胞内Ca2释放通道大家族成员之一,为RyR亚型之一,主要在心肌表达. 一、RyR2的调节 许多结合在胞浆的N末端的调节物参与RyR2功能的调节.内源性调节,除Ca2+外还有下列调节物:(1)环磷酸腺苷依赖的蛋白激酶A(PKA)刺激RyR2,过去认为其在S2030位点磷酸化,后认为S2808为主要PKA磷酸化位点[1].(2)钙/钙调蛋白依赖的蛋白激酶Ⅱ(CaMKⅡ)及其异构型钙/钙调蛋白依赖性丝氨酸/苏氨酸激酶(CaMKⅡδ)[2],均对RyR2起刺激作用,使其在S2814位点磷酸化.
出处 《中华心血管病杂志》 CAS CSCD 北大核心 2014年第5期444-446,共3页 Chinese Journal of Cardiology
  • 相关文献

参考文献27

  • 1Respress JL, van Oort P,J, Li N, et al. Role of RyR2 phosphorylation at S2814 during heart failure progression[ J]. Circ Res,2012,110 : 1474-1483.
  • 2Kushnir A,Shan J, Betzenhauser MJ, et al. Role of CaMK Ⅱ delta phosphorylation of the cardiac ryanodine receptor in the force frequency relationship and heart failure [ J ]. Proc Natl Acad Sci U S A,2010,107 : 10274-10279.
  • 3Van Petegem F. Ryanodine receptors: structure and function[ J ]. J Biol Chem ,2012,287:31624-31632.
  • 4Takano K, Liu D, Tarpey P, et al. An X-linked channelopathy with cardiomegaly due to a CLIC2 mutation enhancing ryanodine receptor channel activity [ J ]. Hum Mol Genet, 2012,21 : 4497- 4507.
  • 5Betzenhauser MJ, Marks AR, Ryanodine receptor ehannelopathies [ J]. Pflugers Arch ,2010,460:467-480.
  • 6Wilders R. Cardiac ion ehannelopathies and the sudden infant death syndrome[ J]. ISRN Cardiol,2012 ,2012 :846171.
  • 7Jiang D, Jones PP, Davis DR, et al. Characterization of a novel mutation in the cardiac ryanodine receptor that results in catecholaminergic polymorphic ventricular tachycardia [ J ]. Channels (Austin) ,2010,4:302-310.
  • 8Meli AC, Refaat MM, Dura M, et al. A novel ryanodine receptor mutation linked to sudden death increases sensitivity to cytosolic calcium[ J ]. Circ Res,2011,109 :281-290.
  • 9Hsiao PY, Tien HC, Lo CP, et al. Gene mutations in cardiac arrhythmias: a review of recent evidence in ion channelopathies [ J]. Appl Clin Genet,2013,6 : 1-13.
  • 10Kujala K, Paavola J, Lahti A, et al. Cell model of catecholaminergie polymorphic ventricular tachycardia reveals early and delayed afterdepolarizations [ J ]. PLoS One,2012,7 : e44660.

二级参考文献24

  • 1李翠兰,张莉,胡大一,崔长琮,刘文玲,滕思勇,王擎,无.85例中国人长QT综合征先证者的临床特征及有关基因突变研究现状[J].中华心律失常学杂志,2004,8(6):328-334. 被引量:20
  • 2郭成军,张英川,方冬平,刘冰,郝蓬,李庆祥,何东方,李果.短QT综合征多频率室性心动过速和心室颤动的机理与消融治疗[J].中国心脏起搏与心电生理杂志,2005,19(1):23-28. 被引量:50
  • 3Sumitomo N,Harada K,Nagashima M,et al.Catecholaminergic polymorphic ventricular tachycardia:Electrocardiographic characteristics and optimal therapeutic strategies to prevent sudden death[J].Heart,2003,89:66-70.
  • 4Priori S,Napolitano C,Tiso N.Mutations in the cardiac ryanodine receptor gene underlie catecholaminergic polymorphic ventricular tachycardia[J].Circulation,2000,102:49-53.
  • 5Lahat H,Pras E,Olender T,et al.Missense mutation in a highly conserved region of CASQ2 is associated with autosomal recessive catecholamine-induced polymorphic ventricular tachycardia in Bedouin families from Israel[J].Am J Hum Genet,2001,69:1378-1384.
  • 6Chen YH,Xu SJ,Bendahhou S,et al.KCNQ1 gain-of-function mutation in familial atrial fibrillation[J].Science,2003,299(5604):251-254.
  • 7Schulze-Bahr E,Neu A,Friederich P,et al.Pacemaker channel dysfunction in a patient with sinus node disease[J].J Clin Invest,2003,111:1537-1545.
  • 8Benson DW,Wang DW,Dyment M,et al.Congenital sick sinus syndromev caused by recessive mutations in the cardiac sodium channel gene(SCN5A)[J].J Clin Invest,2003,112:1019-1028.
  • 9Bezzina CR,Rook MB,Groenewegen WA,et al.Compound heterozygosity for mutations (W156X and R225W) in SCN5A associated with severe cardiac conduction disturbances and degenerative changes in the conduction system[J].Circ Res,2003,92:159-168.
  • 10Smits JP,Koopmann TT,Wilders R,et al.A mutation in the human cardiac sodium channel (E161K) contributes to sick sinus syndrome,conduction disease and Brugada syndrome in two families[J].J Mol Cell Cardiol,2005,38:969-981.

共引文献15

同被引文献52

  • 1赵鹏军,孙锟.钙/钙调素依赖的蛋白激酶II对心肌细胞钙循环的影响[J].国外医学(生理病理科学与临床分册),2004,24(4):357-359. 被引量:3
  • 2李荣,易岂建,钱永如,刘晓燕.卡维地洛对心力衰竭时兰尼碱受体的作用[J].中华儿科杂志,2005,43(8):603-607. 被引量:7
  • 3孙英贤.心律失常的药物治疗进展[J].实用药物与临床,2006,9(2):73-75. 被引量:5
  • 4陈桂荣,陈玉彬.新型钙增敏剂的研究进展[J].实用药物与临床,2006,9(2):123-125. 被引量:2
  • 5McCauley MD, Wehrens XH. Ryanodine receptor phosphorylation, calcium/calmodulin-dependent protein kinase I , and life-threat- ening ventricular arrhythmias[J].Trends Cardiovasc Med, 2011, 21(2) :48-51.
  • 6Song YH. A Memory Molecule, Ca(2 + )/ca|modulin-dependent protein kinase ]I and redox stress; key factors for arrhythmias in a diseased heart[J]. Korean Circ J, 2013,43(3) :145-151.
  • 7Dobrev D, Wehrens XH. Calmodulin kinase ticulum Ca2 ~ leak, and atrial fibrillation [ J ] Med, 2010,20(1 ) :30-34.
  • 8Trends Cardiovasc Anderson ME, Brown JH, Bers DM. CaMK ]l in myocardial hy pertrophy and heart failure[ J]. J Mol Cell Cardiol, 2011,51 (4) 468-473.
  • 9Bets DM, Grandi E. Calcium/ealmodulin-dependent kinase H regulation of cardiac ion channels [ J ]. J Cardiovasc Pharmacol, 2009,54(3 ) : 180-187.
  • 10Respress JL, van Oort R J, Li N, et al. Role of RyR2 phospho~yla- tion at $2814 during heart failure progression [J]. Circ Res, 2012,110( 11 ) : 1474-1483.

引证文献2

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部